EUVIMEDEUVIMED entdecken
Open Access

Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts

Zujian Xiong, Kyle M Walsh iD, Chaim T Sneiderman, Michal Nisnboym, Costas G Hadjipanayis, Sameer Agnihotri, Todd N Eagar, Hong Wang, Ian F Pollack, Thomas G Forsthuber, Xuejun Li, Itay Raphael und 1 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Zujian Xiong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, HLA Antigens, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Xiangya School of Medicine, Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individual-level characteristics underlying population-level variation in glioma risk and outcomes remain incompletely understood. Cancer immunosurveillance, host immunity, and some immunotherapies center on the ability of an individual’s immune cells to recognize antigen epitopes presented on major histocompatibility complex molecules. Inter-individual variation in human leukocyte antigen (HLA) alleles can elicit distinct repertoires of tumor antigen for presentation to immune cells. Therefore, HLA alleles may impact glioma incidence and prognosis.

Methods

HLA class I (HLA-I) alleles were identified using sequencing data from 4 large glioma cohorts and healthy cohorts, matched on ancestry, and race- and age-matched imputed cohorts developed by the Hardy-Weinberg equilibrium were referred to determine odds ratio incidence estimated by logistic regression. HLA prognostication was quantified by Cox regression.

Results

We analyzed 1215 cases of glioma patients from non-Hispanic Whites and Asians. The HLA-I allelic frequencies of gliomas generally corresponded to their distribution within each race. However, specific HLA-I alleles were significantly associated with glioma incidence and prognosis, which differ between races but were independent of age and sex. Notably, non-Hispanic White glioma patients exhibited greater HLA homozygosity rates compared with race-matched controls. HLA-C01:02 and HLA-C07:02 displayed opposing effects on glioma prognosis between races. The distinct effects were associated with their capability of presenting specific mutations that appeared at the initial or late phase of glioma progression.

Conclusions

Expression of specific HLA-I alleles are associated with glioma incidence and prognosis within race. HLA-I-homozygosity is a risk factor for glioma in non-Hispanic Whites. These findings may guide the development of precision-guided immunotherapies for glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsHLA AntigensBiomarkers, TumorHumansMaleFemalePrognosisMiddle AgedAdultCohort StudiesCase-Control StudiesGene FrequencyAgedFollow-Up StudiesAlleles

Stichwörter der Autor:innen

HLA-Igliomahomozygosityincidenceprognosis

Substanzen

HLA AntigensBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
  • Xiangya School of Medicine, Central South University, Changsha, China.
  • Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • College of Medicine, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Kyle M Walsh, Gary Kohanbash

Förderung

  • NIH HHS
  • Xiangya School of Medicine, Central South University

Zitieren

APA

Xiong, Z., Walsh, K. M., Sneiderman, C. T., Nisnboym, M., Hadjipanayis, C. G., Agnihotri, S., Eagar, T. N., Wang, H., Pollack, I. F., Forsthuber, T. G., Li, X., Raphael, I., & Kohanbash, G. (2025). Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf040

Vancouver

Xiong Z, Walsh KM, Sneiderman CT, Nisnboym M, Hadjipanayis CG, Agnihotri S, et al. Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf040

BibTeX
@article{Xiong2025,
  author = {Xiong, Zujian and Walsh, Kyle M and Sneiderman, Chaim T and Nisnboym, Michal and Hadjipanayis, Costas G and Agnihotri, Sameer and Eagar, Todd N and Wang, Hong and Pollack, Ian F and Forsthuber, Thomas G and Li, Xuejun and Raphael, Itay and Kohanbash, Gary},
  title = {Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf040}
}
Kostenlos starten →